Cargando…
Cellular immunotherapy directed against human cytomegalovirus as a novel approach for glioblastoma treatment
Glioblastoma multiforme (GBM) has a very poor prognosis, despite multimodal therapy including surgery, radiation and chemotherapy. A novel adoptive immunotherapy that exploits the presence of cytomegalovirus antigens in malignant brain cancer cells has been shown to be safe and elicit potential clin...
Autores principales: | Schuessler, Andrea, Walker, David G, Khanna, Rajiv |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Landes Bioscience
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4108464/ https://www.ncbi.nlm.nih.gov/pubmed/25083342 http://dx.doi.org/10.4161/onci.29381 |
Ejemplares similares
-
Cytomegalovirus as a Novel Target for Immunotherapy of Glioblastoma Multiforme
por: Schuessler, Andrea, et al.
Publicado: (2014) -
A new approach for cellular immunotherapy of nasopharyngeal carcinoma
por: Smith, Corey, et al.
Publicado: (2012) -
Immunological targeting of cytomegalovirus for glioblastoma therapy
por: Nair, Smita K, et al.
Publicado: (2014) -
Mutations in glioblastoma oncosuppressive pathways pave the way for oncomodulatory activity of cytomegalovirus
por: Hollon, Todd C, et al.
Publicado: (2013) -
DKK1 as a novel target for myeloma immunotherapy
por: Qian, Jianfei, et al.
Publicado: (2012)